AS

Ajay Sangal

Director Director DIN 05276860
DIN 05276860 First appointment May 2012 Primary industry Professional Services
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2012
Shareholding value •••• Premium profile

About Ajay Sangal

Data last updated:

Ajay Sangal was a Director at Theraxy Private Limited (2016–2022) and Director at Nilyam Pharmaceuticals Private Limited (2012–2014). The companies operate in Professional Services and Trading.

DIN 05276860
Primary Designation Director
Industry Professional Services
First Appointment 29 May 2012

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Theraxy Private Limited U74110UP2016PTC076789
Director24 Feb 20162016₹10.3 Lakh (FY 2025)Active
Director29 May 20122012₹3.9 Lakh (FY 2017)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Theraxy Private Limited
Nilyam Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ajay Sangal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ajay Sangal

Ajay Sangal was first appointed on 29 May 2012 as Director at Nilyam Pharmaceuticals Private Limited. The most recent appointment on record is 24 Feb 2016 at Theraxy Private Limited.

Ajay Sangal held 2 earlier board appointments: Theraxy Private Limited (Director, 24 Feb 2016 to 07 Nov 2022); Nilyam Pharmaceuticals Private Limited (Director, 29 May 2012 to 06 Mar 2014).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available